Observed and Expected Survival in Men and Women After Suffering a STEMI.
gender
life expectancy
myocardial infarction
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
19 Apr 2020
19 Apr 2020
Historique:
received:
25
03
2020
revised:
16
04
2020
accepted:
17
04
2020
entrez:
25
4
2020
pubmed:
25
4
2020
medline:
25
4
2020
Statut:
epublish
Résumé
Mortality caused by ST elevation myocardial infarction (STEMI) has declined because of greater use of primary percutaneous coronary intervention (PCI). It is unknown if patients >75 have similar survival as peers. We aim to know it stratifying by sex and assessing how the sex may impact the survival. We retrospectively selected all patients >75 who suffered a STEMI treated with primary PCI at our institution. We compared their survival with that of the reference population (general population matched by age, sex, and geographical region). A Cox-regression analysis controlling for clinical factors was performed to know if sex was a risk factor. Total of 450 patients were studied. Survival at 1, 3, and 5 years of follow-up for patients who survived the first 30 days was 91.22% (CI95% 87.80-93.72), 79.71% (CI95% 74.58-83.92), and 68.02% (CI95% 60.66-74.3), whereas in the reference population it was 93.11%, 79.10%, and 65.01%, respectively. Sex was not a risk factor, Hazard Ratio = 1.02 (CI95% 0.67-1.53; Life expectancy of patients suffering a STEMI is nowadays intimately linked to survival in the first 30 days. After one year, the risk of death for both men and women seems similar to that of the general population.
Identifiants
pubmed: 32325887
pii: jcm9041174
doi: 10.3390/jcm9041174
pmc: PMC7230566
pii:
doi:
Types de publication
Journal Article
Langues
eng
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Eur Heart J. 2018 Jan 7;39(2):119-177
pubmed: 28886621
JAMA. 2009 Aug 26;302(8):874-82
pubmed: 19706861
N Engl J Med. 1999 Jul 22;341(4):217-25
pubmed: 10413733
J Am Coll Cardiol. 2015 Nov 3;66(18):1961-1972
pubmed: 26515998
Rev Esp Cardiol (Engl Ed). 2020 Mar 5;:
pubmed: 32147402
Chest. 2004 Aug;126(2):461-9
pubmed: 15302732
J Natl Cancer Inst Monogr. 2014 Nov;2014(49):145-86
pubmed: 25417231
J Clin Med. 2020 Feb 25;9(3):
pubmed: 32106425
Arch Intern Med. 2009 Oct 26;169(19):1767-74
pubmed: 19858434
Lancet. 2017 Apr 1;389(10076):1323-1335
pubmed: 28236464
Am Heart J. 2010 Jul;160(1):80-87.e3
pubmed: 20598976
Am J Cardiol. 2006 Nov 1;98(9):1140-3
pubmed: 17056314
Int J Cardiol. 2013 Sep 30;168(2):1041-7
pubmed: 23168004
Lancet. 2003 Jan 4;361(9351):13-20
pubmed: 12517460
Eur Heart J. 2010 Mar;31(6):684-90
pubmed: 19933516
J Am Heart Assoc. 2018 Jun 30;7(13):
pubmed: 29960995
J Am Coll Cardiol. 2013 Mar 26;61(12):1222-30
pubmed: 23500325
Eur J Cancer. 2011 Sep;47(14):2202-10
pubmed: 21549589
J Am Coll Cardiol. 2019 Jul 9;74(1):26-33
pubmed: 31272548
JAMA Intern Med. 2018 May 1;178(5):632-639
pubmed: 29630703
J Am Coll Cardiol. 2014 Nov 18-25;64(20):2101-8
pubmed: 25457398
Heart. 2014 Apr;100(7):582-9
pubmed: 24436220
Eur Heart J. 2016 Jan 1;37(1):24-34
pubmed: 26530104
Am Heart J. 2008 May;155(5):862-8
pubmed: 18440333
Eur Heart J. 2011 Mar;32(6):706-11
pubmed: 21196443
Am Heart J. 2014 Mar;167(3):376-83
pubmed: 24576523
Eur Heart J. 2006 Mar;27(6):729-36
pubmed: 16478749
BMJ Open. 2017 Sep 21;7(9):e015241
pubmed: 28939567
J Am Heart Assoc. 2017 Mar 20;6(3):
pubmed: 28320749
Am Heart J. 2011 Jan;161(1):91-7
pubmed: 21167339